MS Stem for researchers

MS Stem is a biobank of human induced pluripotent stem cell (iPSC) lines, derived from people living with and without multiple sclerosis. The biobank provides researchers with fully characterised iPSC lines from well phenotyped and genotyped individuals. This provides a unique opportunity to research the pathophysiology of MS in human cell models or conduct preclinical screening of putative therapeutics.

• View and download the MS Stem standard operating procedures.
• Review the MS Governance Committee terms of reference (ToR).

The iPSCs will be made available (cost-recovery basis) to national and international researchers for the purpose of non-commercial research only.

1. Review list of available iPSC lines
2. Review material transfer agreement (MTA)
3. Download and complete your application form
4. Email us your application form.

For more information contact us.

Induced pluripotent stem cell derived pericytes respond to mediators of proliferation and contractility (Stem Cell Research & Therapy, March 2024)

Generation and characterisation of four multiple sclerosis iPSC lines from a single family (Stem Cell Research, July 2022)

Using MS induced pluripotent stem cells to investigate MS aetiology (Multiple Sclerosis & Related Disorders, July 2022)

Generation of MNZTASi001-A, a human pluripotent stem cell line from a person with primary progressive multiple sclerosis (Stem Cell Research, December 2021)